FC
Finepoint Capital LP
High-turnover traderSector-focusedContrarian
Total reported value
$2.0B
Reporting period: 2026-03-31 · Number of holdings: 9
Finepoint Capital LP disclosed 9 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $2.0B and a quarterly turnover rate of 91.4%.
Personality snowflake
- Concentration
- 97.81
- Portfolio Stability
- 91.42
- Momentum/Contrarian
- 0
- Sector conviction
- 100
- Diversification
- 18
- Sizing Uniformity
- 88.38
Recent moves
Trim SPY
-33.0% -$386.9M
Trim QXO
-34.6% -$139.4M
Add RXO
+7.3% $28.6M
Add ANNAW
0.0% $327.6K
Add ANNA
0.0% $150.8K
New buy SOXX
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 35.13% | -18.41% | -32.96% | |
| 2 | SOXX | Ishares Semiconductor ETF | ETF-Other | 24.74% | +24.74% | NEW | |
| 3 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 18.76% | +18.76% | NEW | |
| 4 | QXO | Qxo INC | Stock-Industrials | 13.78% | -6.61% | -34.56% | |
| 5 | RXO | Rxo INC | Stock-Other | 7.54% | +1.62% | +7.29% | |
| 6 | ANNAW | Aleanna INC - Cl A - 29 | Stock-Other | 0.02% | +0.02% | — | |
| 7 | ANNA | Aleanna INC | Stock-Other | 0.01% | +0.01% | — | |
| 8 | ✓ | Moneyhero Limited | Stock-Other | — | — | — | |
| 9 | CLDI | Calidi Biotherapeutics INC | Stock-Other | — | — | — |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 9 | $2.0B | 91 | |
| 2025-12-31 | 9 | $2.0B | 16 | |
| 2025-09-30 | 9 | $1.7B | 61 | |
| 2025-06-30 | 10 | $1.4B | 0 | |
| 2025-03-31 | 25 | $1.3B | 100 | |
| 2024-12-31 | 26 | $1.6B | 0 | |
| 2024-09-30 | 26 | $1.4B | 0 | |
| 2024-06-30 | 25 | $352.3M | 0 | |
| 2024-03-31 | 26 | $389.9M | 0 | |
| 2023-12-31 | 27 | $317.0M | 0 | |
| 2023-09-30 | 30 | $200.8M | 0 | |
| 2023-06-30 | 37 | $289.1M | 0 | |
| 2023-03-31 | 38 | $261.8M | 0 | |
| 2022-12-31 | 44 | $309.3M | 0 | |
| 2022-09-30 | 57 | $304.0M | 0 | |
| 2022-06-30 | 60 | $289.2M | 0 | |
| 2022-03-31 | 63 | $300.8M | 0 | |
| 2021-12-31 | 71 | $390.1M | 0 | |
| 2021-09-30 | 74 | $585.7M | 0 | |
| 2021-06-30 | 43 | $533.4M | 0 | |
| 2021-03-31 | 1 | — | 100 | |
| 2020-12-31 | 1 | $2.5M | 100 | |
| 2020-09-30 | 1 | $83.1M | 100 | |
| 2020-06-30 | 1 | — | 100 | |
| 2020-03-31 | 1 | $170.1M | 100 | 178462F |
| 2019-12-31 | 1 | $212.4M | 58 | |
| 2019-09-30 | 2 | $339.2M | 100 | |
| 2019-06-30 | 3 | $194.5M | 20 | |
| 2019-03-31 | 3 | $217.4M | 100 | |
| 2018-12-31 | 3 | $165.2M | 100 | |
| 2018-09-30 | 3 | $244.7M | 38 | |
| 2018-06-30 | 3 | $200.3M | 49 | |
| 2018-03-31 | 6 | $331.1M | 61 | |
| 2017-12-31 | 10 | $542.8M | 33 | |
| 2017-09-30 | 9 | $449.0M | 26 | |
| 2017-06-30 | 7 | $388.6M | 31 | |
| 2017-03-31 | 6 | $322.8M | 41 | |
| 2016-12-31 | 5 | $213.5M | 6 | |
| 2016-09-30 | 5 | $225.6M | 12 | |
| 2016-06-30 | 5 | $206.8M | 25 | |
| 2016-03-31 | 5 | $170.5M | 14 | |
| 2015-12-31 | 5 | $155.7M | 51 | |
| 2015-09-30 | 7 | $254.6M | 30 | |
| 2015-06-30 | 9 | $344.6M | 32 | |
| 2015-03-31 | 9 | $298.0M | 45 | |
| 2014-12-31 | 6 | $229.8M | 0 |
Holding changes this quarter
Finepoint Capital LP's most significant position changes for 2026-03-31: New buy: Ishares Semiconductor ETF (SOXX); Sold out: Ishares Russell 2000 ETF (IWM); New buy: Invesco Qqq Trust Series 1 (QQQ); Sold out: Solid Biosciences INC (SLDB); Trim: Ss Spdr S&p 500 ETF Trust-us (SPY) — shares -32.96%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RXO | Rxo INC | +1.6% | +7.29% | Add |
| 2 | ANNAW | Aleanna INC - Cl A - 29 | 0% | — | Unchanged |
| 3 | ANNA | Aleanna INC | 0% | — | Unchanged |
| 4 | ✓ | Moneyhero Limited | — | — | Unchanged |
| 5 | CLDI | Calidi Biotherapeutics INC | — | — | Unchanged |
| 6 | QXO | Qxo INC | -6.6% | -34.56% | Trim |
| 7 | SPY | Ss Spdr S&p 500 ETF Trust-us | -18.4% | -32.96% | Trim |
| 8 | SOXX | Ishares Semiconductor ETF | — | NEW | New buy |
| 9 | IWM | Ishares Russell 2000 ETF | — | EXIT | Sold out |
| 10 | QQQ | Invesco Qqq Trust Series 1 | — | NEW | New buy |
| 11 | SLDB | Solid Biosciences INC | — | EXIT | Sold out |
FAQ
What is Finepoint Capital LP and what type of investor is it?
Finepoint Capital LP is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $2.0B, spread across 9 disclosed positions.
What are Finepoint Capital LP's largest equity positions?
Based on the latest 13F filing, Finepoint Capital LP's top holdings by market value are:
1. Ss Spdr S&p 500 ETF Trust-us (SPY) — $685.9M (35.1%)
2. Ishares Semiconductor ETF (SOXX) — $483.1M (24.7%)
3. Invesco Qqq Trust Series 1 (QQQ) — $366.4M (18.8%)
4. Qxo INC (QXO) — $269.1M (13.8%)
5. Rxo INC (RXO) — $147.3M (7.5%)
What changes did Finepoint Capital LP make in its most recent portfolio filing?
In the latest reported quarter, Finepoint Capital LP made 7 notable position adjustments: 2 new positions were initiated, 1 existing holdings were added to, 2 positions were partially reduced, and 2 were completely exited. The largest of these moves: New buy: Ishares Semiconductor ETF (SOXX); Sold out: Ishares Russell 2000 ETF (IWM); New buy: Invesco Qqq Trust Series 1 (QQQ); Sold out: Solid Biosciences INC (SLDB); Trim: Ss Spdr S&p 500 ETF Trust-us (SPY) — shares -32.96%
What sectors does Finepoint Capital LP focus on?
Finepoint Capital LP is concentrated in the following sectors based on its current disclosed equity portfolio:
• Industrials: 100.0%